Concepedia

Publication | Closed Access

Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:

41

Citations

21

References

2009

Year

Abstract

Women in the SPIRIT III trial had inherently higher MACE and TVF rates than men. However, the angiographic and clinical benefits of using XIENCE V stents are generalizable to women.

References

YearCitations

Page 1